Activation of the LKB1/AMPK pathway by terpenoids inhibits fatty acid synthesis, enhances mitochondrial β‐oxidation, and reduces lipase expression, improving non‐alcoholic steatohepatitis (NASH) and preventing NAFLD progression (Omidkhoda et al. 2023). This evidence concerns the gene STK11 and metabolic dysfunction-associated steatohepatitis.